Circulating tumor DNA-based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.

被引：0
|
作者：
Fusco, Brendon
Tsai, Jill
Clemens, Keelia
Gulhati, Pat
机构：
[1] Rutgers Canc Inst New Jersey, Dept Hematol & Med Oncol, New Brunswick, NJ USA
[2] Guardant Hlth Inc, Redwood City, CA USA
[3] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
747
引用
收藏
页码：747 / 747
页数：1
相关论文
共 50 条
  • [31] Immunotherapy Outcomes in KRAS Mutated vs KRAS Wild-Type Advanced Lung Adenocarcinoma
    Collons, D.
    Nguyen, R.
    Khan, M.
    Schwartz, C.
    Pasquinelli, M.
    Feldman, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S409 - S410
  • [32] Tumor suppressive effects of wild-type Hras on oncogenic Kras-driven pancreatic tumorigenesis
    Weyandt, Jamie D.
    Counter, Christopher M.
    CANCER RESEARCH, 2014, 74 (19)
  • [33] Circulating tumor DNA-based mutational landscape of advanced colorectal cancer.
    Yan, Fang
    Gao, Wei
    Zhu, Lifei
    Xie, Wenzhuan
    Gao, Chan
    Zhao, Jing
    Huang, Mengli
    Cai, Shangli
    Zhong, Yi
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] Increased mutant KRAS gene dosage drives pancreatic cancer progression: evidence for wild-type KRAS as a tumor suppressor?
    Kent, Oliver A.
    HEPATOBILIARY SURGERY AND NUTRITION, 2018, 7 (05) : 403 - 405
  • [35] Circulating tumor DNA for recurrence monitoring following resection for pancreas adenocarcinoma.
    Amini, Neda
    Koti, Shruti
    Ascherman, Benjamin
    King, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
    Heining, Christoph
    Horak, Peter
    Uhrig, Sebastian
    Codo, Paula L.
    Klink, Barbara
    Hutter, Barbara
    Froehlich, Martina
    Bonekamp, David
    Richter, Daniela
    Steiger, Katja
    Penzel, Roland
    Endris, Volker
    Ehrenberg, Karl Roland
    Frank, Stephanie
    Kleinheinz, Kortine
    Toprak, Umut H.
    Schlesner, Matthias
    Mandal, Ranadip
    Schulz, Lothar
    Lambertz, Helmut
    Fetscher, Sebastian
    Bitzer, Michael
    Malek, Nisar P.
    Horger, Marius
    Giese, Nathalia A.
    Strobel, Oliver
    Hackert, Thilo
    Springfeld, Christoph
    Feuerbach, Lars
    Bergmann, Frank
    Schroeck, Evelin
    von Kalle, Christof
    Weichert, Wilko
    Scholl, Claudia
    Ball, Claudia R.
    Stenzinger, Albrecht
    Brors, Benedikt
    Froehling, Stefan
    Glimm, Hanno
    CANCER DISCOVERY, 2018, 8 (09) : 1087 - 1095
  • [37] EGFR and KRAS Mutations in Lung Parenchyma of Subjects With EGFR/KRAS Wild-Type Lung Adenocarcinoma
    Chalela, Roberto
    Gonzalez-Garcia, Jose Gregorio
    Khilzi, Karys
    Curull, Victor
    Sanchez-Font, Albert
    Longaron, Raquel
    Rodrigo-Calvo, Maria Teresa
    Martin-Ontiyuelo, Clara
    Gea, Joaquim
    Bellosillo, Beatriz
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [38] Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer
    Singh, Harshabad
    Keller, Rachel B.
    Kapner, Kevin S.
    Dilly, Julien
    Raghavan, Srivatsan
    Yuan, Chen
    Cohen, Elizabeth F.
    Tolstorukov, Michael
    Andrews, Elizabeth
    Brais, Lauren K.
    da Silva, Annacarolina
    Perez, Kimberly
    Rubinson, Douglas A.
    Surana, Rishi
    Giannakis, Marios
    Ng, Kimmie
    Clancy, Thomas E.
    Yurgelun, Matthew B.
    Schlechter, Benjamin L.
    Clark, Jeffrey W.
    Shapiro, Geoffrey I.
    Rosenthal, Michael H.
    Hornick, Jason L.
    Nardi, Valentina
    Li, Yvonne Y.
    Gupta, Hersh
    Cherniack, Andrew D.
    Meyerson, Matthew
    Cleary, James M.
    Nowak, Jonathan A.
    Wolpin, Brian M.
    Aguirre, Andrew J.
    CLINICAL CANCER RESEARCH, 2023, 29 (22) : 4627 - 4643
  • [39] Circulating tumor cells as a surrogate for treatment response in patients with metastatic pancreatic adenocarcinoma.
    Parekh, Hiral D.
    Starr, Jason Scott
    Varillas, Jose I.
    Ivey, Alison Marguerite
    Barnes, Isis
    McEwan, Margaret A.
    Trevino, Jose Gilberto
    Cioffi, Jessica
    Hughes, Steven J.
    Grajo, Joseph
    Fan, Z. Hugh
    Allegra, Carmen Joseph
    George, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [40] Cell free circulating tumor DNA ERBB2 amplifications are targetable in patients with pancreatic ductal adenocarcinoma.
    Barzi, Afsaneh
    Raymond, Victoria
    Wang-Gillam, Andrea
    Lanman, Richard B.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345